Cellular energetics as a target for tumor cell elimination


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Investigation of cancer cell metabolism has revealed variability of the metabolic profiles among different types of tumors. According to the most classical model of cancer bioenergetics, malignant cells primarily use glycolysis as the major metabolic pathway and produce large quantities of lactate with suppressed oxidative phosphorylation even in the presence of ample oxygen. This is referred to as aerobic glycolysis, or the Warburg effect. However, a growing number of recent studies provide evidence that not all cancer cells depend on glycolysis, and, moreover, oxidative phosphorylation is essential for tumorigenesis. Thus, it is necessary to consider distinctive patterns of cancer metabolism in each specific case. Chemoresistance of cancer cells is associated with decreased sensitivity to different types of antitumor agents. Stimulation of apoptosis is a major strategy for elimination of cancer cells, and therefore activation of mitochondrial functions with direct impact on mitochondria to destabilize them appears to be an important approach to the induction of cell death. Consequently, the design of combination therapies using acclaimed cytotoxic agents directed to induction of apoptosis and metabolic agents affecting cancer cell bioenergetics are prospective strategies for antineoplastic therapy.

作者简介

P. Maximchik

Faculty of Basic Medicine

Email: Vladimir.Gogvadze@ki.se
俄罗斯联邦, Moscow, 119991

A. Kulikov

Faculty of Basic Medicine

Email: Vladimir.Gogvadze@ki.se
俄罗斯联邦, Moscow, 119991

B. Zhivotovsky

Faculty of Basic Medicine; Institute of Environmental Medicine

Email: Vladimir.Gogvadze@ki.se
俄罗斯联邦, Moscow, 119991; Box 210, Stockholm, 17177

V. Gogvadze

Faculty of Basic Medicine; Institute of Environmental Medicine

编辑信件的主要联系方式.
Email: Vladimir.Gogvadze@ki.se
俄罗斯联邦, Moscow, 119991; Box 210, Stockholm, 17177


版权所有 © Pleiades Publishing, Ltd., 2016
##common.cookie##